Toggle light / dark theme

The Nuts and Bolts of Better Brains: Harnessing the Power of Neuroplasticity

What if your brain at 77 were as plastic as it was at 7? What if you could learn Mandarin with the ease of a toddler or play Rachmaninoff without breaking a sweat? A growing understanding of neuroplasticity suggests these fantasies could one day become reality. Neuroplasticity may also be the key to solving diseases like Alzheimer’s, depression, and autism. In this program, leading neuroscientists discuss their most recent findings and both the tantalizing possibilities and pitfalls for our future cognitive selves.

PARTICIPANTS: alvaro pascual-leone, nim tottenham, carla shatz.

MODERATOR: Guy McKhann.

MORE INFO ABOUT THE PROGRAM AND PARTICIPANTS: https://www.worldsciencefestival.com/programs/nuts-bolts-bet…lasticity/

This program is part of the BIG IDEAS SERIES, made possible with support from the JOHN TEMPLETON FOUNDATION.

- SUBSCRIBE to our YouTube Channel and “ring the bell” for all the latest videos from WSF

Biotech: Human Modification and Augmentation

Start listening with a 30-day Audible trial and your first audiobook is free. Visit.
http://www.audible.com/isaac or text “isaac” to 500–500.
In the future Biotechnology may allows us repair, modify, or augment humans, but how will this be done? What will these technologies look like and should we embrace them?

Visit our Website: http://www.isaacarthur.net.
Support us on Patreon: https://www.patreon.com/IsaacArthur.
Facebook Group: https://www.facebook.com/groups/1583992725237264/
Reddit: https://www.reddit.com/r/IsaacArthur/
Twitter: https://twitter.com/Isaac_A_Arthur on Twitter and RT our future content.
SFIA Discord Server: https://discord.gg/53GAShE

Listen or Download the audio of this episode from Soundcloud: Episode’s Audio-only version: https://soundcloud.com/isaac-arthur-148927746/biotech-human-…gmentation.
Episode’s Narration-only version: https://soundcloud.com/isaac-arthur-148927746/biotech-human-…ation-only.

Credits:
Biotech: Human Modification and Augmentation.
Science & Futurism with Isaac Arthur.
Episode 289, May 6, 2021

Produced & narrated by isaac arthur.

Writers:

DNA Manipulation in Living Subjects

Try Dashlane here: https://www.dashlane.com/isaacarthur.
Get 10% off now with my promo code: isaacarthur.
Genetic Engineering and DNA alteration is an emerging technology with huge ramifications in the future, including potentially altering the DNA of adult humans, not just embryos or plants & animals.

Visit our Website: http://www.isaacarthur.net.
Support us on Patreon: https://www.patreon.com/IsaacArthur.
SFIA Merchandise available: https://www.signil.com/sfia/
Social Media:
Facebook Group: https://www.facebook.com/groups/1583992725237264/
Reddit: https://www.reddit.com/r/IsaacArthur/
Twitter: https://twitter.com/Isaac_A_Arthur on Twitter and RT our future content.
SFIA Discord Server: https://discord.gg/53GAShE

Listen or Download the audio of this episode from Soundcloud: Episode’s Audio-only version:
https://soundcloud.com/isaac-arthur-148927746/dna-manipulati…g-subjects.
Episode’s Narration-only version: https://soundcloud.com/isaac-arthur-148927746/dna-manipulati…ation-only.

Credits:
DNA Manipulation in Living Subjects.
Episode 227; Feb 27, 2020

Writers:
Isaac Arthur.

Editors:

Tech Bro Thinks He’s Close to Cheating Death

A stem cell researcher who founded his startup with the psychedelic-loving German billionaire Christian Angermayer, Peyer believes that aging is a disease that humans can fight with pharmaceuticals. He plans to prove it first by identifying disorders and diseases that mimic aging, such as those that cause loss of muscle mass, and then partner with researchers studying medicines for said diseases.


A bold proposal: that by 2050, a 70-year-old will look and feel like they’re 50.

That’s the gamble that 35-year-old James Peyer is taking with this Cambrian Biopharma “longevity startup,” the Times of London reports.

“Of our 100,000-year-plus history as a species, it’s been for only about 75 years that these diseases of ageing have been the primary predators of humankind,” he told the newspaper. “We are rapidly zeroing in on our biggest predators — diseases of [aging] — and figuring out how to beat them back.”

Ancient Greek drug could cut COVID-19 deaths

An ancient Greek drug derived from the saffron plant could improve the treatment of people with severe COVID-19 and reduce the COVID mortality rate by as much as 50%, according to a report published earlier this month in the European Journal of Internal Medicine by an Israeli researcher from the Hebrew University of Jerusalem and Hadassah Medical School.

The drug, colchicine, dates back thousands of years to ancient Egypt, where it was known for its special healing properties. It is one of a few medicines that survived until modern times. Most recently, it has been used to treat and prevent inflammation caused by gout that can lead to painful arthritis and Familial Mediterranean Fever (FMF), which is common among Jewish people of North African descent.


Prof. Ami Schattner researched and analyzed all patients treated in controlled trials of this ancient drug for the past 20 years. He found that among its uses and potential uses, colchicine also appears effective in treating COVID-19.

Top Articles By JPost

Making lasers more efficient, versatile and compact

Their inner workings reside in the realm of physics, but lasers make everyday life possible. Talking on a cell phone or googling COVID stats while your apples and oranges are scanned at the checkout counter—lasers at every step.

Lasers emit at specific wavelengths. At one wavelength, laser beams etch patterns on computer chips that define their circuitry. At telecom wavelengths, lasers fire the enormous volumes of data through optical fibers that make ours the information age.

In 2017, a new kind of laser invented by electrical engineer Boubacar Kante, Ph.D., was recognized as one of the breakthrough inventions of the year by Physics World. With his Bakar Fellows support, Kante is preparing to fabricate a prototype of the new laser and demonstrate its potential for a range of applications from microsurgery to satellite telemetry.

Israeli co. kicks off COVID oral vaccine trial in South Africa

The first volunteer in a Phase I clinical trial of an oral COVID-19 vaccine developed by an Israeli-American company has been screened and enrolled, according to Oravax Medical, a subsidiary of Oramed Pharmaceuticals.

The trial is taking place in South Africa.

Oramed Pharmaceuticals, a clinical-stage pharmaceutical company, is based on technology developed by Hadassah-University Medical Center and run by Israeli CEO Nadav Kidron.

Oravax developed a novel oral virus-like particle (VLP) COVID-19 vaccine based on the Oramed’s “POD” oral delivery technology that can be used to orally administer a number of protein-based therapies, which would otherwise be delivered by injection.


Volunteers for Oramed’s medical trial will receive two doses of the oral COVID vaccine three weeks apart.

A new vaccine that alters senescent cells in a way that pushes the immune system into removing them

Sorry if re-post…


A team of researchers affiliated with a large number of institutions in Japan has developed a vaccine that tricks the immune system into removing senescent cells. In their paper published in the journal Nature Aging, the group describes their vaccine, how it works and how effective it was when given to test mice.

Prior research has shown that part of the aging process is the development of —cells that outlive their usefulness but fail to die naturally. Instead, they produce chemicals that can lead to inflammation, aging and a host of other ailments. Prior research has shown that senescence occurs when cells stop dividing. Prior research has also shown that senescent cells can lead to in some instances and tumor suppression in others. Senescence also plays a role in tissue repair, and its impacts on the body vary depending on factors such as overall health and age. It is suspected that senescence is related to telomere erosion, and in some cases, environmental factors that lead to cell damage. In this new effort, the researchers have developed a vaccine that creates antibodies that attach to senescent cells, marking them for removal by .

The team was able to create the vaccine after identifying a protein made in senescent cells but not in healthy active cells. That allowed them to develop a type of vaccine based on the amino acids in the protein. When injected, the vaccine incites the body to produce antibodies that bind only to senescent cells, and that sets off an immune response that involves sending white blood cells to destroy the senescent cells.